Sugi Predict

Sugi Predict / Compounds / Fotemustine

Fotemustine

Fotemustine

SCHEMBL5508629

CCOP(=O)(OCC)C(C)NC(=O)N(CCCl)N=O.CN(N=O)C(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.57
▸ KDM4E B2RXH2 1/20 0.57
▸ CYP2D6 P10635 1/20 0.57
▸ CYP2C19 P33261 1/20 0.57
▸ MAPK1 P28482 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.32
▸ THRB P10828 1/20 0.32
▸ HK1 P19367 3/20 0.32
▸ HK2 P52789 3/20 0.32
▸ ADRA2A P08913 2/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ PDE4A P27815 1/20 0.30
▸ ADRA1A P35348 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chlorozotocin SCHEMBL8489015 0.95 LMNA (0.48) LMNAKDM4ECYP2D6CYP2C19MAPK1
Chlorozotocin SCHEMBL6051206 0.85 LMNA (0.51) LMNAKDM4ECYP2D6CYP2C19
Chlorozotocin SCHEMBL10424026 0.84 LMNA (0.78) LMNAKDM4ECYP2D6CYP2C19MAPK1
Chlorozotocin SCHEMBL6014822 0.80 LMNA (0.54) LMNAKDM4ECYP2D6CYP2C19
Streptozosin SCHEMBL22408645 0.80 LMNA (0.70) LMNAKDM4ECYP2D6CYP2C19MAPK1
Chlorozotocin SCHEMBL11409484 0.78 LMNA (0.64) LMNAKDM4ECYP2D6CYP2C19MAPK1
Chlorozotocin SCHEMBL8539 0.78 LMNA (0.64) LMNAKDM4ECYP2D6CYP2C19MAPK1
Chlorozotocin SCHEMBL11409480 0.78 LMNA (0.64) LMNAKDM4ECYP2D6CYP2C19MAPK1
Chlorozotocin SCHEMBL1648834 0.78 LMNA (0.64) LMNAKDM4ECYP2D6CYP2C19MAPK1
Fotemustine SCHEMBL16174560 0.78 ALDH1A1 (0.44) LMNACYP2C19ALDH1A1THRBADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1796602-A2 MULTIFUNCTIONAL COMPOUNDS FOR FORMING CROSSLINKED BIOMATERIALS AND METHODS OF PREPARATION AND USE Angiotech Pharmaceuticals (US), Inc. (US) 2007-06-20 — — EP disclosed
WO-2006055008-A2 IMPLANTABLE SENSORS AND IMPLANTABLE PUMPS AND ANTI-SCARRING AGENTS ANGIOTECH INTERNATIONAL AG (CH) 2006-05-26 — — WO disclosed
WO-2006034128-A2 MULTIFUNCTIONAL COMPOUNDS FOR FORMING CROSSLINKED BIOMATERIALS AND METHODS OF PREPARATION AND USE ANGIOTECH BIOMATERIALS CORPORATION (US) 2006-03-30 — — WO disclosed